Search Results - "Ràfols, Carles"

Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry by Esteve-Pastor, María A, Rivera-Caravaca, José M, Roldán, Vanessa, Sanmartin Fernández, Marcelo, Arribas, Fernando, Masjuan, Jaime, Barrios, Vivencio, Cosin-Sales, Juan, Freixa-Pamias, Román, Recalde, Esther, Pérez-Cabeza, Alejandro I, Manuel Vázquez Rodríguez, José, Ràfols Priu, Carles, Anguita Sánchez, Manuel, Lip, Gregory Y H, Marin, Francisco

“…Abstract Background Assessing bleeding risk during the decision-making process of starting oral anticoagulation (OAC) therapy in atrial fibrillation (AF)…”
Get full text

Benefits of Emergency Departments’ Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation) by Coll-Vinent, Blanca, Martín, Alfonso, Sánchez, Juan, Tamargo, Juan, Suero, Coral, Malagón, Francisco, Varona, Mercedes, Cancio, Manuel, Sánchez, Susana, Carbajosa, José, Ríos, José, Casanovas, Georgina, Ràfols, Carles, del Arco, Carmen

“…BACKGROUND AND PURPOSE—Long-term benefits of initiating stroke prophylaxis in the emergency department (ED) are unknown. We analyzed the long-term safety and…”
Get full text

Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban by Marín, Francisco, Fernández, Marcelo Sanmartín, Barón-Esquivias, Gonzalo, Barrios, Vivencio, Lekuona, Iñaki, Pérez-Cabeza, Alejandro I, Masjuan, Jaime, Del Vigo, Esther Recalde, Vázquez Rodríguez, José Manuel, Freixa-Pamias, Roman, Schilling, Vanessa Roldán, Arribas, Fernando, Priu, Carles Rafols, Sánchez, Manuel Anguita

“…It is not well known how comorbidities may change the prognosis of atrial fibrillation (AF) patients. This study was aimed to analyze the impact of…”
Get full text

Type and doses of oral anticoagulants and adherence to anticoagulant treatment in elderly patients with atrial fibrillation: the ESPARTA study by Mostaza, Jose María, Suárez Fernández, Carmen, Castilla Guerra, Luis, Suriñach, Josep Maria, Tamarit, Juan José, Diaz Diaz, José Luis, García Polo, Iluminada, Santamaria, Esther Francia, Fidalgo Fernández, María Angeles, de la Guerra Acebal, Carla, Dávila Ramos, Meliton Francisco, Ràfols, Carles

“…To analyze the use of oral anticoagulants in elderly patients with atrial fibrillation in clinical practice. Cross-sectional and multicenter study performed in…”
Get full text

Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study by Sanmartín Fernández, Marcelo, Anguita Sánchez, Manuel, Arribas, Fernando, Barón-Esquivias, Gonzalo, Barrios, Vivencio, Cosin-Sales, Juan, Esteve-Pastor, María Asunción, Freixa-Pamias, Roman, Lekuona, Iñaki, Pérez-Cabeza, Alejandro I, Ureña, Isabel, Vázquez Rodríguez, José Manuel, Rafols Priu, Carles, Marin, Francisco

“…The aim of the study was to evaluate the performance of the 2MACE in patients with atrial fibrillation (AF) treated with rivaroxaban and to improve the…”
Get full text

Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study by Anguita Sánchez, Manuel, Marín, Francisco, Masjuan, Jaime, Cosín-Sales, Juan, Vázquez Rodríguez, José Manuel, Barrios, Vivencio, Barón-Esquivias, Gonzalo, Lekuona, Iñaki, Pérez-Cabeza, Alejandro I, Freixa-Pamias, Román, Parra Jimenez, Francisco Javier, Monzer Khanji Khatib, Mohamed, Rafols Priu, Carles, Sanmartín Fernández, Marcelo

“…The aim of this study was to analyze the impact of the presence of heart failure (HF) on the clinical profile and outcomes in patients with atrial fibrillation…”
Get full text

Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries by Marin, Francisco, Fernández, Marcelo Sanmartín, Lekuona, Iñaki, Arribas, Fernando, Barón-Esquivias, Gonzalo, Barrios, Vivencio, Cosin-Sales, Juan, Freixa-Pamias, Román, Masjuan, Jaime, Pérez-Cabeza, Alejandro I, Schilling, Vanessa Roldán, Vázquez Rodríguez, José Manuel, Priu, Carles Rafols, Sánchez, Manuel Anguita

“…To analyze the effectiveness and safety of rivaroxaban in patients with atrial fibrillation (AF). The clinical profile and outcomes of the EMIR study were…”
Get full text

Core level photoemission line shape selection: Atomic adsorbates on iron by Acres, Matthew J., Hussain, Hadeel, Walczak, Monika S., Nikiel, Marek, Sewell, Christopher, Rafols i Belles, Carles, Ahmad, Ehsan A., Walton, Alexander S., Muryn, Christopher A., Harrison, Nicholas M., Lindsay, Robert

“…Robust fitting of core level photoemission spectra is often central to reliable interpretation of X‐ray photoelectron spectroscopy (XPS) data. One key element…”
Get full text

Validation of satisfaction questionnaire ACTS in outpatients with atrial fibrillation treated with oral anticoagulants in Spain. ALADIN Study by Suárez, Carmen, Pose, Antonio, Montero-Pérez-Barquero, Manuel, Roquer, Jaume, Gállego, Jaime, Ràfols, Carles, Cazorla, Daniel, Vivancos, José

“…To validate the satisfaction questionnaire Anti-Clot-Treatment Scale (ACTS) in outpatients with nonvalvular atrial fibrillation (NVAF) treated with oral…”
Get more information

Validation of satisfaction questionnaire ACTS in outpatients with atrial fibrillation treated with oral anticoagulants in Spain. ALADIN Study by Suárez, Carmen, Pose, Antonio, Montero-Pérez-Barquero, Manuel, Roquer, Jaume, Gállego, Jaime, Ràfols, Carles, Cazorla, Daniel, Vivancos, José

“…To validate the satisfaction questionnaire Anti-Clot-Treatment Scale (ACTS) in outpatients with nonvalvular atrial fibrillation (NVAF) treated with oral…”
Get full text

New oral anticoagulants vs vitamin K antagonists: benefits for health-related quality of life in patients with atrial fibrillation by Alegret, Josep M, Viñolas, Xavier, Arias, Miguel A, Martínez-Rubio, Antoni, Rebollo, Pablo, Ràfols, Carles, Martínez-Sande, José L

“…New oral anticoagulants (NOAC) have demonstrated their efficacy as an alternative to vitamin K antagonists (VKA) in the prophylaxis of cardioembolic events in…”
Get full text

Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment by Rivera-Caravaca, José Miguel, Anguita Sanchez, Manuel, Sanmartín Fernández, Marcelo, Rafols, Carles, Barón-Esquivias, Gonzalo, Arribas Ynsaurriaga, Fernando, Freixa-Pamias, Román, Lekuona Goya, Iñaki, Vázquez Rodríguez, José Manuel, Pérez-Cabeza, Alejandro I., Cosín-Sales, Juan, Ureña Montilla, Isabel, Álvarez-Vieitez Blanco, Antonio, Marín, Francisco

“…Renal impairment confers worse prognosis in patients with atrial fibrillation (AF) but there is scarce evidence about the influence of direct-acting oral…”
Get full text

Outcomes and factors associated with mortality in patients with atrial fibrillation and heart failure: FARAONIC study by Gómez Doblas, Juan José, Cepeda‐Rodrigo, José María, Agra Bermejo, Rosa, Blanco Labrador, Elvira, Blasco, Maria Teresa, Carrera Izquierdo, Margarita, Lekuona, Iñaki, Recio Mayoral, Alejandro, Rafols, Carles, Manito, Nicolás

“…BackgroundHeart failure (HF) and atrial fibrillation (AF) are common and coexistent conditions.HypothesisTo investigate the adverse events and mortality risk…”
Get full text

Factors associated with disease progression in patients with atrial fibrillation and heart failure anticoagulated with rivaroxaban by Manito, Nicolás, Cepeda‐Rodrigo, José María, Farré, Nuria, Castillo Orive, Miguel, Galve, Enrique, Jiménez‐Candil, Javier, García‐Pinilla, José M., López Sánchez, Eduardo Sebastián, Rafols, Carles, Gómez Doblas, Juan José

“…Background Patients with atrial fibrillation (AF) and heart failure (HF) have a high risk of thromboembolism and other outcomes and anticoagulation is…”
Get full text

Clinical profile and outcomes in very elderly patients with atrial fibrillation anticoagulated with rivaroxaban: data from the EMIR study by Marín, Francisco, Sánchez, Manuel Anguita, Lekuona, Iñaki, Fernández, Marcelo Sanmartín, Barrios, Vivencio, Muñoz, Carlos Perez, Cosín-Sales, Juan, Pérez Cabeza, Alejandro I, Schilling, Vanesa Roldán, Priu, Carles Rafols, Orenes-Piñero, Esteban, Esteve-Pastor, María Asunción

“…To analyze the clinical profile, adequacy of treatment with rivaroxaban and outcomes in octogenarians with atrial fibrillation (AF), taking rivaroxaban in…”
Get full text

Use of rivaroxaban attenuates renal function impairment in patients with atrial fibrillation: insights of the EMIR study by López‐Gálvez, Raquel, Rivera‐Caravaca, José Miguel, Anguita Sánchez, Manuel, Sanmartín Fernández, Marcelo, Rafols, Carles, Pérez‐Cabeza, Alejandro Isidoro, Barón Esquivias, Gonzalo, Lekuona Goya, Iñaki, Vázquez Rodríguez, José Manuel, Cosín Sales, Juan, Arribas Ynsaurriaga, Fernando, Barrios, Vivencio, Freixa‐Pamias, Román, Marín, Francisco

“…Background In atrial fibrillation (AF) patients on vitamin K antagonists, a progressive deterioration of renal function is common but there is limited evidence…”
Get full text

Estudio in vitro del efecto cicatrizante del extracto de cartílago micronizado by Casaroli-Marano, Ricardo, Reina, Manuel, Ràfols, Carles, Vilaró, Senén

“…Los avances en el conocimiento de la biología celular de los fenómenos que participan en las heridas crónicas de la piel han incrementado la búsqueda de…”
Get full text